1. Home
  2. PASG vs SCOR Comparison

PASG vs SCOR Comparison

Compare PASG & SCOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Passage Bio Inc.

PASG

Passage Bio Inc.

SELL

Current Price

$3.77

Market Cap

12.8M

Sector

Health Care

ML Signal

SELL

Logo comScore Inc.

SCOR

comScore Inc.

SELL

Current Price

$3.24

Market Cap

73.8M

ML Signal

SELL

Company Overview

Basic Information
Metric
PASG
SCOR
Founded
2017
1999
Country
United States
United States
Employees
27
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
12.8M
73.8M
IPO Year
2020
2007

Fundamental Metrics

Financial Performance
Metric
PASG
SCOR
Price
$3.77
$3.24
Analyst Decision
Buy
Analyst Count
3
0
Target Price
★ $15.50
N/A
AVG Volume (30 Days)
14.2K
★ 44.9K
Earning Date
11-10-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 127.37
EPS
N/A
★ N/A
Revenue
N/A
★ $403,549,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 1.02
52 Week Low
$3.29
$2.50
52 Week High
$20.00
$9.34

Technical Indicators

Market Signals
Indicator
PASG
SCOR
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
PASG
SCOR

About PASG Passage Bio Inc.

Passage Bio Inc is a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases. Their primary focus is the development and advancement of cutting-edge, one-time gene therapies designed to target critical underlying pathologies in these conditions. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target the critical underlying pathology of neurodegenerative diseases. The pipeline having PBFT02.

About SCOR comScore Inc.

comScore Inc is a information and analytics company that measures advertising, content, and the consumer audiences of each, across media platforms. It create products using a data platform that combines information on digital platforms (connected televisions, mobile devices, tablets and computers), televisions, direct to consumer applications, and movie screens with demographics and other descriptive information. The company has developed proprietary data science that enables measurement of person-level and household-level audiences, removing duplicated viewing across devices and over time. Its segments include Content & Ad Measurement and Research & Insight Solutions of which the Content & Ad Measurement segment derives the majority of the revenue.

Share on Social Networks: